Literature DB >> 12084307

Peyronie's disease: advances in basic science and pathophysiology.

T J Bivalacqua1, S K Purohit, W J Hellstrom.   

Abstract

Peyronie's disease is an idiopathic, localized connective tissue disorder of the penis that involves the tunica albuginea of the corpus cavernosum and the adjacent areolar space. The tunica albuginea plays an important role in the mechanism of erection. Peyronie's disease is characterized by local changes in the collagen and elastic fiber composition of the tunica albuginea. The formation of fibrotic plaques alters penile anatomy and can cause different degrees of bending, narrowing, or shortening of the penis. Moreover, a significant number of men with Peyronie's disease develop erectile dysfunction. Penile blood flow studies in many patients with Peyronie's disease suggest a strong association with veno-occlusive dysfunction. Although long recognized as an important clinical entity of the male genitalia, the etiology of this disease has remained poorly understood. The following review focuses on recent research on the pathophysiology of Peyronie's disease.

Entities:  

Mesh:

Year:  2000        PMID: 12084307     DOI: 10.1007/s11934-000-0010-8

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  38 in total

1.  Nitric oxide: a physiologic mediator of penile erection.

Authors:  A L Burnett; C J Lowenstein; D S Bredt; T S Chang; S H Snyder
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

2.  The effect of surgical trauma on rat tunica albuginea.

Authors:  A I El-Sakka; C A Selph; T S Yen; R Dahiya; T F Lue
Journal:  J Urol       Date:  1998-05       Impact factor: 7.450

3.  Cellular and biochemical aspects of normal and abnormal wound healing: an overview.

Authors:  R F Diegelmann
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

4.  Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression.

Authors:  A I El-Sakka; H M Hassoba; R J Pillarisetty; R Dahiya; T F Lue
Journal:  J Urol       Date:  1997-10       Impact factor: 7.450

Review 5.  Transforming growth factor beta in tissue fibrosis.

Authors:  W A Border; N A Noble
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

6.  A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression.

Authors:  T J Bivalacqua; E K Diner; T E Novak; Y Vohra; S C Sikka; H C Champion; P J Kadowitz; W J Hellstrom
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

7.  Study of the changes in collagen of the tunica albuginea in venogenic impotence and Peyronie's disease.

Authors:  P H Chiang; C P Chiang; M R Shen; C H Huang; C J Wang; I Y Huang; T Y Shieh
Journal:  Eur Urol       Date:  1992       Impact factor: 20.096

8.  Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease.

Authors:  S Stewart; M Malto; L Sandberg; K K Colburn
Journal:  J Urol       Date:  1994-07       Impact factor: 7.450

9.  The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984.

Authors:  M B Lindsay; D M Schain; P Grambsch; R C Benson; C M Beard; L T Kurland
Journal:  J Urol       Date:  1991-10       Impact factor: 7.450

10.  PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle.

Authors:  R B Moreland; A Traish; M A McMillin; B Smith; I Goldstein; I Saenz de Tejada
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.